ArticleFrontiers in cardiovascular medicine2025
Cardiac computed tomography-derived coronary artery volume to myocardial mass for the prediction of risk stratification for acute coronary syndrome.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The study aimed to assess various characteristics of coronary computed tomography angiography (CCTA) in patients presenting with suspected coronary artery disease (CAD). Additionally, the research sought to investigate the predictive value of the coronary artery volume to myocardial mass (V/M) derived from CCTA in risk stratification for patients with acute coronary syndrome (ACS) and to determine the relationship between the V/M ratio and the Global Registry of Acute Coronary Events (GRACE) risk score in ACS. Methods: This was a single-center, retrospective study. The magnitude of V/M was investigated in patients with ACS ( Results: The Mantel test analysis shows that the key factors of ACS were left ventricle myocardial mass (M), V/M, and coronary CT angiography-derived fractional flow reserve (FFR Conclusions: The V/M ratio is valuable for stratified risk prediction of ACS and is independently associated with the GRACE risk score.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.